Frequently Asked Questions
The market is segmented based on , By Type (Diagnostic and Treatment), Treatment & Diagnostics (Positive Airway Pressure (Pap) Therapy, Oral and Nasal Devices, Airway Systems, Other Devices, Drugs, Surgery, Polysomnography and Polygraphy, and Oximetry and Actigraph), Age Group (Pediatric, Adult, and Geriatric), End User (Hospitals, Sleep Laboratories, Home, and Others) – Industry Trends and Forecast to 2031.
.
The Global Dental Sleep Medicine Market size was valued at USD 6.69 USD Billion in 2023.
The Global Dental Sleep Medicine Market is projected to grow at a CAGR of 5.21% during the forecast period of 2024 to 2031.
The major players operating in the market include Koninklijke Philips N.V. (Netherlands), ResMed (Australia), Fisher & Paykel Healthcare Limited (New Zealand), DeVilbiss Healthcare LLC (U.S.), Curative Medical (U.S.), Apex Dental Sleep Lab (U.S.), BMC Medical Co. Ltd. (China), BD (Becton, Dickinson and Company) (U.S.), Cadwell Industries Inc. (U.S.), Invacare Corporation (U.S.), Compumedics Limited (Australia), Braebon Medical Corporation (Canada), General Electric (U.S.), SomnoMed (Australia), Henry Schein, Inc. (U.S.).
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America.
